Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has been named one of The Wall Street Journal’s “Best on the Street” and among the top-10 analysts in the United States by Institutional Investor. By 2016, companies supplying stem cell products should generate more than $1.2 billion in total revenues and have a combined market value of over $10 billion. Find out about the latest stem cell applications and market trends through the Stem Cell Analysis and Market Forecasts 2006-2016. Almost 350 pages of industry-specific research with forecasts and profiles of more than 100 stem cell companies.
Product samples
Samples for this product is available. Please Login/Register to download these samples.
